Replication Factor C1 Mutation Screening RFC1 80G>A
Comprehensive Genetic Cancer Risk Assessment
The Replication Factor C1 Mutation Screening RFC1 80G>A represents a cutting-edge genetic diagnostic tool designed to identify specific mutations in the RFC1 gene that are strongly associated with increased cancer susceptibility. This sophisticated screening provides invaluable insights into hereditary cancer predisposition, enabling proactive healthcare management and personalized risk assessment strategies.
What Does This Test Measure?
This advanced genetic screening specifically targets the RFC1 gene’s 80G>A mutation, which plays a critical role in DNA replication and repair mechanisms. The test utilizes state-of-the-art End Point PCR + RFLP methodology to detect this specific genetic alteration with exceptional accuracy and reliability.
- Identifies RFC1 80G>A mutation status
- Assesses DNA replication factor functionality
- Evaluates genetic cancer predisposition markers
- Provides comprehensive mutation analysis
Who Should Consider RFC1 Mutation Screening?
This genetic screening is particularly recommended for individuals who exhibit specific risk factors or clinical indications:
- Family history of multiple cancer types
- Early-onset cancer diagnoses
- Unexplained tumor development patterns
- Multiple primary cancers in same individual
- Strong family cancer clustering
- Proactive health management seekers
Clinical Benefits of RFC1 Screening
Undergoing RFC1 80G>A mutation screening offers numerous clinical advantages for comprehensive healthcare management:
- Early detection of genetic cancer predisposition
- Personalized cancer risk assessment
- Informed decision-making for preventive measures
- Family genetic counseling opportunities
- Targeted surveillance and monitoring strategies
- Enhanced treatment planning capabilities
Understanding Your Test Results
Your RFC1 mutation screening results will provide clear genetic information:
- Negative Result: No detected RFC1 80G>A mutation, indicating standard cancer risk profile
- Positive Result: Presence of RFC1 80G>A mutation, suggesting increased cancer susceptibility
- Inconclusive Result: Requires additional testing or clinical correlation
All results should be discussed with qualified healthcare providers who can provide comprehensive interpretation and personalized recommendations based on your specific genetic profile and medical history.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Replication Factor C1 Mutation Screening RFC1 80G>A | $132 USD | $176 USD |
Nationwide Testing Availability
We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.
Take Control of Your Genetic Health
Understanding your genetic cancer risk profile represents a powerful step toward proactive health management. The RFC1 80G>A mutation screening provides critical information that can guide personalized healthcare decisions and preventive strategies.
Ready to schedule your genetic cancer risk assessment? Contact our genetic counseling specialists today at +1(267) 388-9828 or book your appointment online to begin your journey toward comprehensive genetic health understanding.
Our dedicated team of genetic specialists and oncology professionals are committed to providing accurate, reliable testing with rapid 3-4 day turnaround times, ensuring you receive timely results for informed healthcare decisions.
